openPR Logo
Press release

Ewing Sarcoma Therapeutics - Pipeline Analysis Celgene, Novartis, Pfizer, MacroGenics, Inc.

12-13-2018 07:07 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: P&S Intelligence

Ewing Sarcoma Therapeutics - Pipeline Analysis Celgene,

Ewing sarcoma pipeline comprises approximately 29 drug candidates in different stages of development.

Ewing sarcoma is a condition in which formation of cancer or tumor takes place in bones and soft tissues. The symptoms associated with Ewing sarcoma include pain as well as swelling in the chest, back, legs, pelvis and arms, lumps in arms, bone fracture, weight loss, loss of appetite, fatigue, malaise, etc.

Download free report Sample at: https://www.psmarketresearch.com/market-analysis/ewing-sarcoma-therapeutics-pipeline-analysis/report-sample

*Major companies collaborate for the development of Ewing sarcoma pipeline

The research also found that various companies are engaged in collaborations for Ewing sarcoma. In April 2014, NanoSmart Pharmaceuticals Inc. and NanoValent Pharmaceuticals Inc., entered into a research collaboration agreement to find out the feasibility of jointly developing an ANA-conjugated liposomal doxorubicin nanoparticle for the treatment of ovarian cancer and other solid tumors.

Browse report at: https://www.psmarketresearch.com/market-analysis/ewing-sarcoma-therapeutics-pipeline-analysis

*Novel and patented technologies for Ewing sarcoma pipeline

Novel technologies are being used for Ewing sarcoma drug candidates. MacroGenics Inc., has been using Fc Optimization platform for the development of their drug candidates.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=ewing-sarcoma-therapeutics-pipeline-analysis

Some of the key players developing Ewing sarcoma therapeutics include Celgene Corporation, Pfizer Inc., and Novartis AG, and others.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ewing Sarcoma Therapeutics - Pipeline Analysis Celgene, Novartis, Pfizer, MacroGenics, Inc. here

News-ID: 1437011 • Views:

More Releases from P&S Intelligence

Public Safety and Security Market Size, Trends, and Forecast 2024-2032
Public Safety and Security Market Size, Trends, and Forecast 2024-2032
The global public safety and security market is projected to grow from USD 517.6 billion in 2024 to USD 1,214.2 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 11.4% during the forecast period. This growth is driven by technological advancements, such as artificial intelligence (AI) and the Internet of Things (IoT), which enhance smart city initiatives and improve surveillance and emergency response systems. The increasing incidence of
Salesforce Services Market Growth Driven by BFSI Sector Demand
Salesforce Services Market Growth Driven by BFSI Sector Demand
The global Salesforce services market reached a valuation of USD 14.1 billion in 2023 and is projected to grow significantly, reaching USD 48.3 billion by 2030. This robust growth is driven by increasing demand across the banking, financial services, and insurance (BFSI) sectors. Salesforce CRM, known for its high-quality service offerings, supports streamlined operations, efficient communication, and enhanced customer service. It optimizes data management and expedites issue resolution, enabling businesses to
Asset Integrity Management Market Share, Growth and Forecast Report, 2024-2030
Asset Integrity Management Market Share, Growth and Forecast Report, 2024-2030
According to the latest market research study published by P&S Intelligence, the asset integrity management market is projected to generate approximately USD 24.2 billion in revenue in 2024, with an expected compound annual growth rate of 5.9% from 2024 to 2030, reaching USD 34.1 billion by the end of the decade. This growth is driven by global industrialization and urbanization, stringent workplace safety regulations, heightened environmental concerns over poorly maintained
The Rise of Fake Image Detection Solutions: Key Market Insights and Future Trends
The Rise of Fake Image Detection Solutions: Key Market Insights and Future Trend …
The fake image detection market is projected to expand significantly, from an estimated USD 712.2 million in 2024 to USD 5,811.9 million by 2030, reflecting a robust compound annual growth rate (CAGR) of 41.9% from 2024 to 2030. Fake images often involve post-production manipulation, where images are altered so subtly that distinguishing the modifications, such as swapped faces or forged signatures, becomes nearly impossible. The proliferation of AI technology and cloud

All 5 Releases


More Releases for Ewing

Ewing Sarcoma Market (2019-2028) Overview with Size, Patients Population, Total …
Ewing Sarcoma Market Synopsis: Global Ewing Sarcoma Market Insights, Epidemiology and Market Forecast studies the present scenario of market (with the base year being 2018), Key Cross Competition, and the growth prospects of global Ewing Sarcoma market for 2018-2028 definition of Ewing Sarcoma: Ewing sarcoma is a malignant small, round, blue cell tumor. It is a disease in which cancer cells are found in the bone or in soft tissue. The most common
Research Focused On the Ewing Sarcoma Treatment Market Size & Share, Growth, Tre …
The report "Ewing Sarcoma Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025 ", has been prepared based on an in-depth market analysis with inputs from industry experts. The objectives of this study are as follows: To define, describe, and forecast the "Ewing Sarcoma Treatment" market by type, application, component, delivery model, end user, and region To provide detailed information regarding major factors influencing market growth (drivers,
Ewing Sarcoma Global Clinical Trials Review H2 2017
Summary: ReportsWeb.com published “Ewing Sarcoma Global Clinical Trials” from its database. The report reviews top companies involved and enlists all trials pertaining to the company. Report provides latest news for the past three months. Original Content: "Ewing Sarcoma Industry Outlook to 2022-Market Forecasts for Liquefied Natural Gas (LNG), Oil Storage, Pipelines and Gas Processing", is a comprehensive report on midstream oil and gas industry in Algeria. The report provides details such as name,
Ewing Sarcoma Global Clinical Trials Status, Region and Phase Review, H2, 2017
To Understand the Pharmaceutical Industry Status worldwide, Market Research Hub (MRH) has included the latest Forecast report titled “Ewing Sarcoma Global Clinical Trials Review, H2, 2017, provides an overview of Ewing Sarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Ewing Sarcoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers
Ewing Sarcoma Global Clinical Market – Growth & Forecast to 2022 Including Key …
A new research document with title 'Ewing Sarcoma Global Clinical Trials Review, H2, 2017' covering detailed analysis, Competitive landscape, forecast and strategies. The study covers geographic analysis that includes regions and important players/vendors such as Pharma Mar SA, Pfizer , NantWorks etc. The report will help user gain market insights, future trends and growth prospects of Review, H2, 2017 , “Ewing Sarcoma Global Clinical Trials Review, H2, 2017""
Ewing sarcoma has a Promising Pipeline with approximately 29 Drug Candidates
Ewing sarcoma pipeline comprises approximately 29 drug candidates in different stages of development. Ewing sarcoma is a condition in which formation of cancer or tumor takes place in bones and soft tissues. The symptoms associated with Ewing sarcoma include pain as well as swelling in the chest, back, legs, pelvis and arms, lumps in arms, bone fracture, weight loss, loss of appetite, fatigue, malaise, etc. Explore Report Description at: www.psmarketresearch.com/market-analysis/ewing-sarcoma-therapeutics-pipeline-analysis Major companies